Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: A result from five randomized controlled trials

International Journal of Ophthalmology

Volumn 9, Issue 1, 2016, Pages 132-138

  Liu, Xiang Dong ^a   Zhou, Xiao Dong ^a   Wang, Zhi ^a   Shen, Yong Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Diabetic macular edema; Intravitreal injection; Photocoagulation; Triamcinolone acetonide

Indexed keywords

EID: 84955493195     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.18240/ijo.2016.01.22     Document Type: Article

References (28)

1. Liu XD, Zhou XD, Wang Z, Shen HJ. Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema: a systemic review and Meta-analysis. Int J Ophthalmol 2014;7(6):1048-1055.
2. Qi HP, Bi S, Wei SQ, Cui H, Zhao JB. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Curr Eye Res 2012;37:1136-1147.
3. Cho HY, Kang SW, Kim YT, Chung SE, Lee SW. A three-year follow-up of intravitreal triamcinolone acetonide injection and macular laser photocoagulation for diffuse diabetic macular edema. Korean J Ophthalmol 2012;26(5):362-368.
4. Diabetic Retinopathy Clinical Research Network, Googe J, Brucker AJ, Bressler NM, Qin H, Aiello LP, Antoszyk A, Beck RW, Bressler SB, Ferris FL, Glassman AR, Marcus D, Stockdale CR. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina 2011;31 (6): 1009-1027.
5. Wang Y, Shi A, Shi X, Liu W. Clinical observation on treating diabetic macular edema with intravitreal triamcinolone acetonide and laser. Yan Ke Xue Bao 2010;25(1):22-25.
6. Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Retina 2010;30(2):254-259.
7. Maia OO, Takahashi BS, Costa RA, Scott IU, Takahashi WY. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol 2009;147(2):291-297.e2.
8. Aydin E, Demir HD, Yardim H, Erkorkmaz U. Efficacy of intravitreal triamcinolone after or concomitant with laser photocoagulation in nonproliferative diabetic retinopathy with macular edema. Eur Ophthalmol 2009;19(4):630-637.
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1-12.
10. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088-1101.
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109): 629-634.
12. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140(4):695-102.
13. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology 2007;114(12):2162-2167.
14. Lee HY, Lee SY, Park JS. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. Korean J Ophthalmol 2009;23(3):153-158.
15. Gillies MC, McAllister IL, Zhu M, Wong W, Louis D, Arnold JJ, Wong TY. Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. Ophthalmology 2011; 118(5):866-872.
16. Larsson J, Zhu M, Sutter F, Gillies MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005;139(5):802-806.
17. Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007;114(3):525-536.
18. Jonas JB, Martus P, Degenring RF, Kreissig I, Akkoyun I. Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmology 2005;123(10):1338-1343.
19. Al Dhibi HA, Arevalo JF. Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes 2013;4(6):295-302.
20. Al Rashaed S, Arevalo JF. Combined therapy for diabetic macular edema. Middle East Afr J Ophthalmol 2013;20(4):315-320.
21. Steijns D, Duijvesz D, Breedijk MA, van der Heijden GJ. Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review. Acta Ophthalmol 2010;88 (4): 389-393.
22. Liu L, Wu X, Geng J, Yuan Z, Chen L. IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis. PLoS One 2012;7(9):e44683.
23. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Nishijima K, Kamizuru H, Ieki Y, Miyamoto K, Nishiwaki H, Honda Y, Ogura Y. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. invest Ophthalmol Vis Sci 2002;43 (4): 1204-1209.
24. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992;110(8): 1155-1159.
25. Mikosz CA, Smith RM, Kim M, Tyson C, Lee EH, Adams E, Straif-Bourgeois S, Sowadsky R, Arroyo S, Grant-Greene Y, Duran J, Vasquez Y, Robinson BF, Harris JR, Lockhart SR, Török TJ, Mascola L, Park BJ; Fungal Endophthalmitis Outbreak Response Team. Fungal endophthalmitis associated with compounded products. Emerg infect Dis 2014;20(2):248-256.
26. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121(1):57-61.
27. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999;27(6):431-432.
28. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 2008;145(5):854-861.